3--hydroxy-5--(4-isobutylpiperazinyl)benzoxazinorifamycin and torcetrapib

3--hydroxy-5--(4-isobutylpiperazinyl)benzoxazinorifamycin has been researched along with torcetrapib* in 1 studies

Other Studies

1 other study(ies) available for 3--hydroxy-5--(4-isobutylpiperazinyl)benzoxazinorifamycin and torcetrapib

ArticleYear
Three drug indications for patients with peripheral arterial disease bite the dust: report from the American Heart Association meeting 2007 in Orlando.
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 2008, Volume: 35, Issue:1

    Topics: Adrenergic beta-Antagonists; American Heart Association; Anti-Bacterial Agents; Anticholesteremic Agents; Humans; Metoprolol; Peripheral Vascular Diseases; Practice Guidelines as Topic; Quinolines; Rifamycins; United States

2008